GC-304

N/A

Report date: 2023/12/15 16:12:47

Base Information

Drug NameGC-304
Drug Alias NameGC304GC-304
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGlycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 inhibitorsLipoprotein lipase inhibitors
TargetsLipoprotein lipaseGlycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1
Therapy Area/IndicationsHypertriglyceridemiaPancreatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing GeneCradle Gene Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing GeneCradle Gene Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemiaPancreatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A